Clinical trial · Observational
FINancial Toxicity and CAncer REcovery in YOUNG Adults
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The FINCARE-Young study aims to investigate the extent and development of financial toxicity in adolescents and young adults with cancer. The primary purpose of this study is to assess the level of financial burden experienced during the acute phase of cancer treatment and after completion of therapy, and to analyze changes over time. In addition, the study seeks to identify sociodemographic, clinical, and socioeconomic factors associated with financial toxicity, as well as its impact on employment and social reintegration. By focusing on young adult cancer survivors, this study addresses an underexplored population and seeks to generate evidence to improve supportive care strategies and reduce long-term financial consequences of cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Financial Toxicity Related to Cancer Diagnosis and Tretment in Adolescents and Young Adults | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (1)
- label
- Adolescents and Young Adults with Cancer
- description
- This cohort consists of adolescents and young adults aged 18 to 39 years at the time of initial cancer diagnosis who received oncological treatment at a single tertiary care center. Participants have completed their primary cancer therapy and are assessed retrospectively and prospectively. The study does not involve any therapeutic intervention. Data are collected through structured telephone interviews and standardized questionnaires, complemented by clinical data extracted from electronic medical records. The focus of the cohort is to evaluate financial toxicity, socioeconomic factors, and employment-related outcomes following cancer treatment.
Primary outcomes (1)
- measure
- Financial toxicity
- timeFrame
- From the acute phase of cancer treatment to the time of study participation after completion of therapy (retrospective assessment of treatment period and current assessment at follow-up), assessed only at one time point at study enrollment.
- description
- Financial toxicity, assessed using the Comprehensive Score for Financial Toxicity (COST) questionnaire, measured during the acute phase of cancer treatment and at the time of study participation, including change over time.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 50 Years
Show eligibility criteria text
Inclusion Criteria: * Age 18 to 39 years at the time of initial cancer diagnosis * Diagnosis of a malignant neoplasm * Receipt of oncological treatment at the University Medical Center Göttingen * Completion of primary cancer therapy at the time of study participation * Initial diagnosis between 2014 and 2024 * Ability to provide informed consent * Sufficient German language skills to participate in a telephone interview and complete questionnaires Exclusion Criteria: * Age below 18 years or above 39 years at the time of initial cancer diagnosis * No history of malignant disease * Ongoing primary cancer treatment at the time of study participation * Severe cognitive impairment or psychiatric condition preventing reliable participation * Insufficient German language proficiency to complete interviews or questionnaires * Withdrawal of informed consent
References
Publications (0)
Data not yet available